BICILLIN L-A
Bicillin L-A (penicillin G benzathine injectable suspension) Disposable Syringe
Approved
Approval ID
777edd2f-8eaa-38ea-e053-2991aa0aa5bf
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Jan 17, 2024
Manufacturers
FDA
NuCare Pharmaceuticals,Inc.
DUNS: 010632300
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
penicillin G benzathine
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code68071-1824
Application NumberNDA050141
Product Classification
M
Marketing Category
C73594
G
Generic Name
penicillin G benzathine
Product Specifications
Route of AdministrationINTRAMUSCULAR
Effective DateJanuary 17, 2024
FDA Product Classification
INGREDIENTS (8)
LECITHIN, SOYBEANInactive
Code: 1DI56QDM62
Classification: IACT
CARBOXYMETHYLCELLULOSEInactive
Code: 05JZI7B19X
Classification: IACT
POVIDONE, UNSPECIFIEDInactive
Code: FZ989GH94E
Classification: IACT
METHYLPARABENInactive
Code: A2I8C7HI9T
Classification: IACT
PROPYLPARABENInactive
Code: Z8IX2SC1OH
Classification: IACT
SODIUM CITRATE, UNSPECIFIED FORMInactive
Code: 1Q73Q2JULR
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
PENICILLIN G BENZATHINEActive
Quantity: 1200000 [iU] in 2 mL
Code: RIT82F58GK
Classification: ACTIM